Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

You may have noticed a familiar landmark disappearing from your neighborhood corner—the local Rite Aid. Its closure is more ...

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 13.8%. Its stock price has climbed to $65 ...